{"id":207090,"date":"2025-06-23T07:12:14","date_gmt":"2025-06-23T07:12:14","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/207090\/"},"modified":"2025-06-23T07:12:14","modified_gmt":"2025-06-23T07:12:14","slug":"the-new-ozempic-weight-loss-pill-amycretin-could-be-more-effective-than-jabs","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/207090\/","title":{"rendered":"The new Ozempic? Weight-loss pill Amycretin could be more effective than jabs"},"content":{"rendered":"<p>Novo Nordisk, the Danish pharmaceutical company behind amycretin \u2014 and also the maker of Wegovy and Ozempic \u2014 hopes the pill version of amycretin could make weight-loss therapy more accessible, especially in Britain, where around 1.5 million people currently receive weight-loss treatments, mostly as injections prescribed through specialised clinics or by private providers.<\/p>\n","protected":false},"excerpt":{"rendered":"Novo Nordisk, the Danish pharmaceutical company behind amycretin \u2014 and also the maker of Wegovy and Ozempic \u2014&hellip;\n","protected":false},"author":2,"featured_media":207091,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[535,105,4326,370,63907,16,15,10891],"class_list":{"0":"post-207090","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-drugs","9":"tag-health","10":"tag-medication","11":"tag-ozempic","12":"tag-trials","13":"tag-uk","14":"tag-united-kingdom","15":"tag-wegovy"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114731440342355419","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/207090","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=207090"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/207090\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/207091"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=207090"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=207090"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=207090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}